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Abstract
A 45-year-old man presented with a six-month history of progressive dyspnea with productive cough and wheez-
ing. The patient was a heavy smoker and had a history of tongue cancer, hypertension, and asthma. Chest X-ray
and computed tomography showed a mass lesion in the left hilar region and total collapse of the upper left lobe
of the lung. Bronchoscopy revealed a whitish solid tumor obstructing the left upper lobe bronchus. Positron emis-
sion tomography showed increased tracer uptake in the lesion. A thoracoscopic lobectomy of the left upper lobe
of the lung was performed. The final pathologic diagnosis was inflammatory myofibroblastic tumor.
Introduction
Inflammatory myofibroblastic tumor (IMT) of the lung,
also known as plasma cell granuloma or inflammatory
pseudotumor, is a rare disease entity [1]. Diagnosis of
IMT is difficult to establish before surgery because of its
diversified radiologic manifestations. This tumor can be
cystic or homogeneous, endobronchial or parenchymal
with or without clear margins [2]. Complete surgical
resection is the treatment of choice not only to exclude
malignancy but also to achieve a good prognosis [3,4].
We report a case of inflammatory myofibroblastic
tumor that was successfully removed by thoracoscopic
lobectomy.
Case report
A 45-year-old man presented with a 6-month history
of progressive dyspnea with productive cough and
wheezing. The patient had a history of smoking (1
pack per day for 20 years), hypertension and asthma,
which was under regular medical control. He also had
a history of tongue cancer (squamous cell carcinoma,
pT2N0M0, stage II) for which he underwent wide exci-
sion of the right side of the tongue and modified neck
lymph node dissection five years prior to this presenta-
tion. Chest plain film showed a protruding mass sha-
dow in the left hilar region. Costodiaphragmatic angles
were clear. There was increased density over left lung
field with elevation of the left side of the diaphragm.
T h e s ef e a t u r e sw e r ei n d i c a t i v eo fah i l a rm a s so b s t r u c t -
ing the bronchus with collapse of the upper left lobe of
the lung (Fig. 1A). Contrast enhanced computed tomo-
graphy (CT) showed a hilar mass measuring approxi-
mately 35 mm × 28 mm × 15 mm and a collapsed left
upper lobe of the lung. There was weak enhancement in
the arterial phase. The endobronchial part of the tumor
had clear margins along the bronchus of the upper left
lobe of the lung. The distal part of the tumor had indis-
tinct margins along the lung parenchyma. The distal
bronchus was dilated and filled with secretions. There
was no mediastinal lymphadenopathy (Fig. 1B).
Bronchoscopy revealed a whitish tumor obstructing the
left upper bronchus (Fig. 2). Biopsy specimens of the
tumor taken during the bronchoscopic examination
showed evidence of smooth muscle cell proliferation
with focal abnormal mitosis. A smooth muscle cell
tumor of malignant potential was considered. Positron
emission tomography (PET) showed increased fluoro-
deoxyglucose (FDG) uptake in the lesion (Fig. 1C).
The tumor involved the upper left lobe of the lung
and obstructed the bronchus. The patient underwent a
thoracoscopic lobectomy under general anesthesia with
double lumen endotracheal tube placement. The vessels
of the left upper lobe were divided and ligated using an
endoscopic autostapling device. The bronchus of the
upper left lobe was opened by endoscissor. The cutting
margin was checked by examination of frozen sections
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lobe of lung was removed through a port with extended
skin incision 5 cm at the anterior 5th intercostal space.
The orifice of the bronchus was sutured with standard
instrumentation through the utility incision.
The resected tumor was white and elastic, measuring
3.5 cm × 2.5 cm × 1.5 cm in size. It impacted the whole
bronchus of the left upper lobe (Fig. 2). Microscopic
examination revealed a mixture of spindle cells showing
fibroblastic and myofibroblastic differentiation arrayed
in fascicles, or with storiform architecture. The spindle
cells had oval nuclei, fine chromatin, inconspicuous
nucleoli, and bipolar, lightly eosinophilic cytoplasm
(Fig. 2A). Admixed with the spindle proliferation was an
inflammatory infiltrate containing lymphocytes, plasma
cells, and eosinophils. Immunohistochemical analysis
showed positive staining for vimentin (Fig. 2B) and des-
min, and focal positive staining for smooth muscle actin
and cytokeratin (Fig. 2C). The tumor had a low Ki-67
proliferative index. In contrast, the tumor cells were not
reactive to CD34, CD99, or S-100 antibodies. The surgi-
cal resection margins and all regional lymph nodes were
tumor free. Inflammatory myofibroblastic tumor was
diagnosed. At the most recent follow-up (12 months
after operation), the patient was symptom free and there
was no evidence of tumor recurrence on chest CT scan.
Discussion
IMT is an uncommon pulmonary disease. The incidence
rate of IMT among patients with lung resection is
0.04%, and 26% of patients are less than 18 years old
[5]. Airway obstruction in IMT, although rare, normally
presents at an early stage due to obstructive respiratory
symptoms [6]. Most patients are symptomatic. There
are respiratory symptoms, such as cough, dyspnea, fever,
fatigue, and hemoptysis.
Figure 1 (A) Chest plain film. A protruding mass shadow is seen in the left hilar region. The shadow of the left bronchus stops at the mass.
Costodiaphragmatic angles are clear. There is increased density over the left lung field with elevation of the left side of the diaphragm. These
findings are indicative of a hilar mass obstructing the bronchus with collapse of the left upper lobe of lung. (B) Contrast computed tomography
(CT) image, distal part of the tumor. The distal bronchus is dilated and filled with secretions. The margin between the lung parenchyma and
tumor is indistinct. (C) Positron emission tomography (PET) and CT, proximal part of the tumor. An endobronchial tumor with high tracer uptake
and clear margins is visible.
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gery because of its diversified radiologic manifestations
and because it can be difficult to distinguish from malig-
nant tumors on small tissue samples obtained from
bronchoscopic examination or needle biopsy. In fact,
only 6.3% of IMT cases are diagnosed based on analysis
of biopsy specimens alone [6]. In addition, IMT is often
difficult to differentiate from other neoplasms on PET
scan because of the high uptake of tracer in IMT. The
prognosis of IMT is dependent on tumor size (less than
or equal to 3 cm) and complete surgical resection. The
overall 3-year survival rate is about 82% and the overall
5-year survival rate is about 74% [3]. In our case, the
tumor was an endobronchial lesion with clear margins.
We were unable to prove whether the tumor involved
the lung parenchyma.
Surgical management of lesions in the major bronchi
is challenging. In our patient, we performed a thoraco-
scopic technique to cut the adhesion of the major fis-
sure, superior pulmonary vein and pulmonary artery
branches to upper lobe of the lung. We then opened the
left upper bronchus to confirm that the cut end of the
bronchus was free. The bronchus was closed with inter-
rupted sutures.
IMT is characterized histologically by spindle cell pro-
liferation. The tumor is referred to by different names
Figure 2 Bronchoscopic exam shows a whitish tumor obstructing the left upper bronchus.G r o s s .T h et u m o ri m p a c t e dt h ew h o l e
bronchus with clear margins. Microscopically, the biopsy specimen is composed of spindle cells with fibroblastic and myofibroblastic
differentiation arrayed in fascicles. (A) The tumor is mostly limited within the bronchi. In a few foci, pushing of tumor margin to the lung
parenchyma is noted (×20; ×100). Immunohistochemical study demonstrated (B) vimentin (+) (×200), and (C) cytokeratin (focal +), (×200).
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encountered in the lesion: plasma cell granuloma or
tumor, xanthogranuloma, plasma cell/histiocytoma com-
plex, or post inflammatory pseudotumor [7]. Matsubara
et al. used the term inflammatory pseudotumor and
described three subgroups based on the cell type most
encountered in a mass: organizing pneumonia (44%),
fibrous histiocytoma (44%), and lymphoplasmocytic type
(12%) [8]. There are regions of organizing pneumonia in
all cases, and therefore, the current hypothesis is
that IMT might develop in individuals with a past his-
tory of upper respiratory infections or pneumonia. Some
studies, however, suggest that it might be a true
neoplasm as some mutations on chromosome 2p23 of
anaplastic lymphoma kinase are found to be related to
this tumor [9].
Conclusions
Although inflammatory myofibroblastic tumor is rare, it
should be considered in the differential diagnosis of pul-
monary lesions. It is generally a benign lesion, but has
potential for local invasion and recurrence. The diagno-
sis and prognosis are highly dependent on complete sur-
gical resection.
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